SCHEMBL30664654

SCHEMBL30664654

COC(=O)c1c(N(Cc2ccc(F)cc2)C(C)=O)sc2c(Cl)c(O)ccc12

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HSP90AA1 P07900 3/20 0.39
▸ HSP90B1 P14625 2/20 0.39
▸ MEN1 O00255 2/20 0.37
▸ KMT2A Q03164 2/20 0.37
▸ BCL2A1 Q16548 1/20 0.35
▸ RAB9A P51151 2/20 0.35
▸ NPC1 O15118 1/20 0.35
▸ MAPT P10636 4/20 0.34
▸ SMN1; SMN2 Q16637 3/20 0.34
▸ KDM4E B2RXH2 2/20 0.34
▸ HTT P42858 2/20 0.34
▸ NPSR1 Q6W5P4 2/20 0.34
▸ LMNA P02545 1/20 0.34
▸ PDK1 Q15118 1/20 0.33
▸ ALDH1A1 P00352 2/20 0.33
▸ APAF1 O14727 1/20 0.33
▸ TDP1 Q9NUW8 1/20 0.33
▸ ADORA2A P29274 1/20 0.32
▸ ADORA2B P29275 1/20 0.32
▸ ADORA1 P30542 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24682815 1.00 HSP90AA1 (0.39) HSP90AA1HSP90B1MEN1KMT2ABCL2A1
SCHEMBL24683860 0.91 HSP90AA1 (0.36) HSP90AA1HSP90B1KMT2AMAPTSMN1; SMN2
SCHEMBL29799884 0.91 HSP90AA1 (0.36) HSP90AA1HSP90B1KMT2AMAPTSMN1; SMN2
SCHEMBL29799821 0.90 HSP90AA1 (0.39) HSP90AA1HSP90B1MEN1KMT2ARAB9A
SCHEMBL24683203 0.90 HSP90AA1 (0.39) HSP90AA1HSP90B1MEN1KMT2ARAB9A
SCHEMBL24683884 0.89 MAPK8 (0.36) HSP90AA1MEN1KMT2AMAPTKDM4E
SCHEMBL29799816 0.89 MAPK8 (0.36) HSP90AA1MEN1KMT2AMAPTKDM4E
SCHEMBL24683893 0.89 MAPT (0.33) HSP90AA1RAB9ANPC1MAPTSMN1; SMN2
SCHEMBL30664739 0.89 MAPT (0.33) HSP90AA1RAB9ANPC1MAPTSMN1; SMN2
SCHEMBL24683861 0.89 HSP90AA1 (0.40) HSP90AA1HSP90B1RAB9AMAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240174629-A1 2-ACETAMIDO-6-HYDROXY-BENZOTHIOPHENE DERIVATIVES WITH ANTIVIRAL ACTIVITY OTCPHARM JSC (RU) 2024-05-30 — — US disclosed
EP-4293017-A1 2-ACETAMIDO-6-HYDROXY-BENZOTHIOPHENE DERIVATIVES WITH ANTIVIRAL ACTIVITY Otcpharm JSC (RU) 2023-12-20 — — EP disclosed
CN-117222630-A 2-acetamido-6-hydroxy-benzothiophene derivatives having antiviral activity OTC制药公司(JSC) 2023-12-12 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240174629-A1 2-ACETAMIDO-6-HYDROXY-BENZOTHIOPHENE DERIVATIVES WITH ANTIVIRAL ACTIVITY ACE2, ACE, EIF2AK2 HSP90AA1 890/4885HSP90B1 2446/4885MEN1 4654/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback